propos
novel
cheminformat
approach
combin
structur
ligandbas
design
identifi
targetspecif
pharmacophor
welldefin
exclus
abil
strategi
includ
predict
select
interact
develop
structur
knowledgebas
select
pharmacophor
model
follow
databas
screen
molecular
dock
uniqu
strategi
employ
address
offtarget
toxic
cdk
connect
eukaryot
cell
apoptosi
extens
potenc
inhibitor
block
cell
death
made
potenti
drugdiscoveri
target
mani
grievou
human
disord
phylogenet
close
relat
cdk
suggest
offtarget
protein
inhibitor
employ
novel
comput
approach
design
ligand
candid
potenti
inhibitori
welldefin
exclus
abil
cdk
structureligand
base
select
pharmacophor
model
model
use
retriev
molecul
zinc
databas
hit
retriev
screen
molecular
dock
proteinligand
interact
fingerprint
base
result
four
molecul
predict
select
antagonist
anticip
uniqu
approach
extend
investig
proteinligand
specif
herein
introduc
novel
comput
screen
strategi
consid
ligand
featur
receptor
inform
identif
targetspecif
inhibitor
ration
approach
includ
deriv
energi
base
pharmacophor
epharmacophor
individu
protein
use
build
select
pharmacophor
sequenti
employ
screen
chemic
databas
select
pharmacophor
model
ensur
essenti
featur
individu
protein
requir
inhibit
conserv
taken
consider
sequenti
screen
also
confirm
final
hit
essenti
featur
requir
select
toward
singl
protein
best
knowledg
methodolog
previous
describ
identifi
select
inhibitor
present
articl
uniqu
strategi
demonstr
implement
classic
exampl
glycogen
synthas
kinas
cyclin
depend
kinas
cdk
offtarget
toxic
toxic
lead
caus
attrit
stage
drug
develop
process
safetyrel
attrit
occur
preclin
level
earlier
design
process
might
exact
major
portion
time
money
pharmaceut
compani
despit
tremend
advanc
scienc
technolog
drug
develop
strang
effici
approach
tackl
offtarget
effect
drug
consequ
offtarget
toxic
increas
apac
prompt
desper
need
effect
strategi
molecular
crosstalk
toxic
drug
attribut
molecular
featur
ensu
molecular
crosstalk
differ
protein
rather
target
protein
henc
burgeon
need
develop
inhibitor
bind
select
target
protein
address
toxic
relat
attrit
highli
conserv
evolutionari
serinethreonin
kinas
histor
depict
central
protein
requir
glycogen
metabol
howev
mount
evid
indic
multifunct
enzym
involv
variou
crucial
pathway
insulin
signal
wnt
pathway
play
crucial
role
synapt
plastic
memori
format
signific
function
kinas
role
phosphoryl
apoptot
regul
cell
death
relat
factor
thu
promot
cellular
degener
henc
emerg
one
attract
therapeut
target
develop
select
antogonist
promis
new
drug
numer
debilit
diseas
alzheim
diseas
ischem
stroke
chronic
inflammatori
process
cancer
diabet
inhibitor
develop
thu
far
often
show
offtarget
effect
due
seriou
limit
specif
low
specif
inhibitor
due
fact
atp
bind
site
highli
conserv
among
divers
protein
kinas
even
extrem
promis
antagonist
produc
offtarget
effect
induc
chang
protein
kinas
especi
archetyp
kinas
central
regul
drive
cell
phase
mitosi
inhibit
key
protein
neg
consequ
cellcycl
progress
cdk
belong
famili
cmgc
kinas
share
high
degre
sequenc
structur
homolog
henc
strategi
implement
develop
select
inhibitor
percept
exclud
achiev
goal
exploit
energet
analysi
proteinligand
dock
elucid
key
featur
protein
ligand
molecular
interact
employ
knowledgebas
coher
pose
deriv
structurebas
pharmacophor
cdk
manual
develop
select
pharmacophor
visual
analysi
three
pharmacophor
appli
select
pharmacophor
virtual
screen
vs
protocol
identifi
select
inhibitor
exclus
abil
cdk
fig
crystal
structur
pdb
id
pdb
id
complex
respect
antagonist
obtain
protein
data
bank
sinc
fig
pipelin
depict
select
inhibitor
design
crystal
structur
avail
built
homolog
model
report
structur
employ
molecular
model
structur
protein
complex
prepar
use
protein
prepar
wizard
tool
schroding
llc
water
molecul
delet
bond
order
assign
hydrogen
ad
metal
treat
appropri
present
next
orient
side
chain
structur
gln
asn
flip
necessari
provid
maximum
degre
hbond
interact
charg
state
residu
optim
final
restrain
minim
protein
structur
perform
use
opl
forc
field
backbon
atom
fix
prepar
protein
structur
use
gener
glide
score
grid
subsequ
dock
calcul
crystal
structur
protein
grid
box
default
size
center
correspond
activ
site
posit
default
paramet
use
constraint
includ
grid
gener
inform
bind
pocket
protein
ligand
import
reveal
true
bind
mechan
conduct
mutagenesi
studi
bind
pocket
consist
set
residu
least
one
heavi
atom
distanc
heavi
atom
ligand
criterion
origin
use
defin
bind
pocket
atp
complex
later
prove
quit
use
identifi
function
domain
stimul
relev
truncat
experi
similar
approach
also
use
defin
bind
pocket
mani
receptorligand
interact
import
drug
design
bind
pocket
manual
defin
either
select
amino
acid
residu
span
kinas
domain
select
ligand
present
within
crystal
structur
gener
select
pharmacophor
model
recent
develop
epharmacophor
approach
employ
construct
energyoptim
pharmacophor
epharmacophor
coalesc
ligand
receptorbas
techniqu
use
inhibitor
librari
probe
pharmacophor
featur
necessari
select
inhibit
method
advantag
combin
pharmacophor
percept
proteinligand
energet
term
rank
import
pharmacophor
featur
combin
approach
attempt
take
step
beyond
simpl
contact
score
incorpor
structur
energet
inform
obtain
dock
librari
ligand
protein
obtain
chembl
web
site
http
wwwebiacukchembldb
use
probe
interact
type
chemic
feasibl
geometri
involv
activ
site
ligand
bind
structur
annot
expand
proton
tautomer
state
use
ligprep
ioniz
state
ph
epik
gener
grid
file
prepar
receptor
cdk
use
glidexp
dock
calcul
glide
dock
modul
write
xp
descriptor
inform
option
enabl
rest
paramet
kept
default
xp
score
function
use
order
best
rank
compound
specif
interact
like
cation
stack
brief
dock
model
inhibitor
refin
use
glide
xp
glide
xp
score
term
comput
energi
map
atom
epharmacophor
site
automat
gener
phase
use
default
set
six
chemic
featur
hbond
acceptor
hbond
donor
hydrophob
h
neg
ioniz
n
posit
ioniz
p
aromat
ring
r
manner
pharmacophor
deriv
protein
repres
later
evalu
manual
gener
select
model
best
pharmacophor
hypothesi
aaddrrr
select
base
care
observ
featur
score
align
ligand
structur
gener
hypothes
select
pharmacophor
hypothesi
encompass
follow
featur
two
hbond
acceptor
select
pharmacophor
model
aaddrrr
use
queri
retriev
potenti
inhibitor
zinc
chemic
databas
million
compound
virtual
screen
carri
use
zincpharm
use
pharmacophor
effici
search
zinc
databas
fix
conform
pharmacophor
match
accomplish
best
similar
search
use
constraint
includ
maximum
rmsd
obey
rotat
bond
cutoff
molecular
weight
rang
dalton
compound
match
well
pharmacophor
featur
aaddrrr
hypothesi
retriev
hit
consid
molecular
dock
studi
dock
studi
perform
use
glide
run
window
xp
glide
algorithm
estim
systemat
search
posit
orient
conform
ligand
enzymebind
pocket
via
seri
hierarch
filter
shape
properti
receptor
symbol
grid
variou
dissimilar
set
field
furnish
precis
score
ligand
pose
potenti
hit
compound
lowest
rmsd
standard
molecular
weight
consid
dock
analysi
hit
subject
hydrogen
addit
remov
salt
ioniz
gener
lowenergi
ring
conform
use
ligprep
tautom
ligand
gener
optim
partial
atom
charg
comput
use
forc
field
vs
workflow
maestro
use
dock
score
leadlik
compound
first
step
glide
run
highthroughput
virtual
screen
mode
topscor
ligand
kept
move
onto
glide
singl
precis
sp
stage
topscor
lead
glidesp
retain
dock
glide
xp
default
valu
accept
van
der
waal
scale
input
partial
charg
use
dock
process
gscore
use
select
best
conform
ligand
gscore
base
chemscor
includ
stericclash
term
add
buri
polar
atom
devis
schroding
penal
electrostat
mismatch
gscore
vdw
coul
lipo
hbond
buryp
rotb
site
demonstr
effect
describ
strategi
addit
dock
experi
carri
compar
select
abil
method
previous
report
comput
approach
identif
inhibitor
select
potent
ligand
report
earlier
inhibit
ligand
prepar
use
ligprep
conform
flexibl
sought
confgen
tool
schroding
suit
final
lowenergi
structur
ligand
gener
employ
xp
dock
activ
site
gener
select
pharmacophor
model
epharmacophor
uniqu
strategi
blend
benefici
aspect
structurebas
ligandbas
techniqu
mount
evid
indic
advantag
incorpor
proteinligand
interact
analysi
convent
ligand
inform
alon
use
inhibitor
librari
protein
probe
pharmacophor
featur
necessari
select
inhibit
method
advantag
combin
pharmacophor
percept
proteinligand
energet
term
rank
import
pharmacophor
featur
proteinligand
base
approach
attempt
take
step
beyond
simpl
contact
score
incorpor
structur
energet
inform
use
score
function
glide
extra
precis
xp
overal
pharmacophor
site
predict
protein
pharmacophor
hypothes
analyz
care
expect
pharmacophor
hypothes
exhibit
high
degre
similar
especi
base
recognit
part
kinas
adr
pharmacophor
model
fig
understand
ideal
pharmacophor
possess
featur
addit
redact
discrimin
featur
care
observ
protein
structur
pharmacophor
conclud
addit
donor
aromat
featur
base
recognit
featur
would
ideal
exclus
strategi
final
hypothesi
aaddrrr
consist
two
hbond
acceptor
two
hbond
donor
three
aromat
ring
r
featur
intersit
distanc
featur
shown
fig
hdonor
map
carboxyl
group
hbond
acceptor
map
peptidyl
amino
group
indic
strong
influenc
possibl
inhibit
two
aromat
featur
occupi
hydrophob
cleft
base
recognit
site
acceptor
aromat
featur
crucial
select
span
ribos
pocket
activ
site
fig
ribos
pocket
compar
wider
henc
former
toler
bulkier
group
posit
compar
cdk
thu
energet
favor
featur
encompass
specif
interact
requir
select
protein
inform
prove
help
develop
new
inhibitor
pharmacophorebas
method
wide
use
virtual
screen
applic
structurebas
pharmacophor
vs
provid
advantag
ligandbas
pharmacophor
approach
use
spatial
inform
target
protein
topolog
descript
ligandreceptor
interact
also
provid
effici
altern
dockingbas
vs
continu
repres
specif
ligandprotein
interact
moreov
recent
studi
indic
structurebas
pharmacophor
approach
provid
detail
inform
accuraci
descript
ligand
bind
ligandbas
method
vs
perform
identifi
possibl
lead
compound
zinc
databas
zinc
chemic
databas
druglik
compound
consist
million
structur
divers
small
molecul
screen
queri
use
zincpharm
tool
molecul
fit
well
pharmacophor
featur
aaddrrr
retriev
hit
sinc
activ
site
larg
hit
may
larger
size
may
violat
lipinski
rule
five
avoid
possibl
inappropri
predict
molecular
weight
cutoff
dalton
rang
rmsd
cutoff
limit
rotat
bond
filter
appli
altogeth
structur
queri
retriev
compound
zinc
databas
molecular
dock
comput
techniqu
tri
predict
desir
conform
ligand
fit
receptor
site
protein
dock
especi
use
second
step
virtual
screen
identif
molecul
fit
pharmacophor
refin
retriev
hit
also
remov
fals
posit
vs
hit
prepar
use
ligprep
dock
cdk
use
glide
lowenergi
stereoisom
structur
gener
ultim
give
rise
isom
dock
calcul
carri
use
vs
workflow
dock
interfac
softwar
final
bind
mode
ten
structur
protein
obtain
dock
rank
exhibit
convent
interact
requir
inhibit
kinas
activ
viz
interf
atp
bide
abil
hydrophob
interact
hydrophob
cleft
form
hing
residu
depict
hbond
interact
ligand
occupi
hdonor
hbond
acceptor
pharmacophor
hydrophob
cleft
map
two
aromat
featur
aaddrrr
hypothesi
howev
dock
ligand
cdk
protein
show
interact
suggest
low
affin
ligand
cdk
activ
site
tabl
c
visual
fig
assum
aromat
group
face
steric
clash
glu
residu
cdk
wherea
well
toler
steric
clash
ligand
activ
site
cdk
tend
disori
ensu
low
affin
ligand
cdk
activ
site
order
demonstr
effect
approach
perform
compar
dock
analysi
fifteen
ligand
collect
previous
report
comput
work
ligand
employ
dock
ligand
show
nearli
ident
glidescor
suggest
high
affin
ligand
cdk
activ
site
well
tabl
comparison
evalu
glidescor
ligand
deriv
approach
indic
greater
select
toward
tabl
mani
marvel
biolog
function
protein
profound
dynam
mechan
reveal
studi
intern
motion
likewis
accur
identifi
ligandbind
pocket
realli
understand
interact
protein
receptor
ligand
consid
static
structur
concern
also
dynam
inform
obtain
simul
intern
motion
dynam
process
make
effort
regard
futur
studi
mount
evid
implic
play
import
role
onset
mani
grievou
human
diseas
recent
data
illustr
contribut
activ
apoptosi
suggest
design
develop
select
small
molecul
inhibitor
may
good
therapeut
option
treatment
numer
human
diseas
associ
apoptosi
studi
new
protocol
select
lead
identif
propos
protocol
combin
ligand
structurebas
approach
highli
nearli
ident
dock
score
ligand
three
protein
indic
equal
affin
toward
target
protein
pharmacophor
studi
spatial
align
compound
usual
one
key
step
obtain
meaning
result
figur
show
good
align
dock
ligand
pharmacophor
pharmacophor
model
use
screen
potenti
compound
zinc
databas
vs
process
fetch
ligand
hit
filter
dock
analysi
final
four
hit
obtain
dock
procedur
demonstr
better
dock
score
glide
energi
greater
select
toward
conclus
unifi
pharmacophor
model
screen
molecular
dock
manual
interpret
approach
altogeth
develop
new
methodolog
identifi
select
inhibitor
fig
delin
import
interact
respons
bind
select
ligand
activ
site
effect
protocol
may
use
identif
specif
lead
molecul
potenti
drug
target
well
